MYM's Joint Venture Company BioHemp Signs LOI for the Sale of $25 Million of CBD-Rich Hemp Biomass

"I am truly excited to share that our sales team has secured a LOI for $25 million, representing nearly half of our remaining forecasted CBD-rich hemp biomass," said Howard Steinberg, CEO of MYM. "The recipient of the biomass represents a consortium of Canada's largest cannabis LP's and is a great vote of confidence to the quality of BioHemp's Canadian grown CBD-rich hemp." "I am truly excited to share that our sales team has secured a LOI for$25 million, representing nearly half of our...

VANCOUVER, British Columbia, 23/07/2019 (informazione.news - comunicati stampa - varie)

"I am truly excited to share that our sales team has secured a LOI for $25 million , representing nearly half of our remaining forecasted CBD-rich hemp biomass," said Howard Steinberg , CEO of MYM. "The recipient of the biomass represents a consortium of Canada's largest cannabis LP's and is a great vote of confidence to the quality of BioHemp's Canadian grown CBD-rich hemp."

MYM Nutraceuticals Inc. is an innovative company focused on the global growth of Cannabis and CBD-rich hemp. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada , Germany and the USA under the following symbols: (CSE:MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).

ON BEHALF OF THE BOARD

Howard Steinberg , CEO
MYM Nutraceuticals Inc.
www.mym.ca

Billy Casselman
778-522-2261
investors@mym.ca

Keep up to date with MYM on our social media channels:
Twitter: @mymnutra
Facebook: @mymnutra
Instagram: @mymnutra